title: [The opportunities for genic therapy of chronic obliterating diseases of lower limbs arteries].
authors.forename: Iu A
authors.initials: IuA
authors.lastname: Cherviakov
authors.forename: I N
authors.initials: IN
authors.lastname: Staroverov
authors.forename: E G
authors.initials: EG
authors.lastname: Nersesian
authors.forename: O N
authors.initials: ON
authors.lastname: Vlasenko
authors.forename: A A
authors.initials: AA
authors.lastname: Isaev
authors.forename: R V
authors.initials: RV
authors.lastname: Deev
mesh_terms: D000328:Adult; D043925:Angiogenesis Inducing Agents / Q000627:therapeutic use; D016903:Drug Monitoring; D005260:Female; D015316:Genetic Therapy; D006801:Humans; D007511:Ischemia; D035002:Lower Extremity / Q000098:blood supply*; D008297:Male; D018919:Neovascularization, Physiologic / Q000235:genetics*; D058729:Peripheral Arterial Disease / Q000503:physiopathology / Q000628:therapy*; D010957:Plasmids; D012720:Severity of Illness Index; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics* / Q000627:therapeutic use
chemical_list: D043925:Angiogenesis Inducing Agents; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A